Topic: Product Liability Cases
Patients allege that Gilead held off on developing its better HIV candidates until older drugs neared the end of their patent lives.
AbbVie scored a major reduction of damages in a retrial of an AndroGel liability case brought by plaintiff Jesse Mitchell.
Merck's appeal to the Supreme Court has drawn in the U.S. Solicitor General, and the outcome could reverberate across the pharmaceutical industry.
After three wins in cases over the risks of blockbuster blood thinner Xarelto, Bayer and Johnson & Johnson have encountered their first defeat.
A lawsuit alleges J&J has "blatantly lied" for decades about talc safety, accusing the company of participating in a conspiracy to conceal the truth.
In one legal expert's view, Johnson & Johnson will continue to take a tough stand against thousands of talc cases.
AbbVie lost the first jury trial in a series of bellwether AndroGel cases, to the tune of $150 million in damages.
Janssen and Bayer are in court again defending Xarelto against claims it caused a patient’s death.
A set of women claiming Pfizer’s blockbuster statin Lipitor caused their diabetes have the right to go back to California state court to make their case.
Johnson & Johnson and its attorneys have come up victorious in a new talc powder jury decision.
